US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily Biotech Top 5 Bull 2X ETF

34.97

-2.9448-7.77%

Volume:597

Turnover:20.88K

Market Cap:2.62M

PE:- -

High:34.97

Open:34.97

Low:34.97

Close:37.91

52wk High:45.88

52wk Low:25.71

Shares:75.00K

Float Shares:75.00K

Volume Ratio:0.90

T/O Rate:0.80%

Dividend:0.76

Dividend Rate:2.19%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Regeneron Pharmaceuticals - Sanofi Enter Sixth Amendment to License and Collaboration Agreement - SEC Filing

THOMSON REUTERS

Regeneron Pharmaceuticals - Ipr&D Charge Expected to Reduce Q3 2026 Gaap and Non-Gaap EPS by $0.18 - SEC Filing

THOMSON REUTERS

Regeneron to Present Phase 3 C-POST Overall Survival Update for Adjuvant Libtayo in High-Risk CSCC at ESMO 2026

Sanofi Can Move Forward to Pursue Deals

Moderna Inc. Stock Rises 6.9%, Outperforms Peers

Vortex Energy Launches Study on Natural Hydrogen and Helium at Robinsons River Salt Project

Nurix, Gilead Extend Research Term for Oncology Program by Two Years for $10 Million Fee

Nurix Extends Gilead Collaboration for Oncology Program

Nurix - Eligible for up to $1.30 Bln in Total Payments as of May 31, 2026

THOMSON REUTERS

Nurix - Eligible for Mid-Single-Digit to Low-Teens Percentage Tiered Royalties

THOMSON REUTERS

Nurix - to Receive $10 Mln Research Term Extension Fee

THOMSON REUTERS

Nurix - Retains Co-Development and 50/50 Profit Sharing Options on Two U.S. Programs

THOMSON REUTERS

Gilead CEO Daniel O’Day Disposes of USD 2,216,507.50 in Common Shares

Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors

Amgen Inc. Stock Underperforms Friday When Compared to Competitors

Legend Biotech Faces Pressure From Rivals Ahead of Key FDA Decision, UBS Says

MT Newswires Live

Amgen’s Evolocumab Study Signals Quiet Efficiency Gains for Cholesterol Franchise

European Equities Traded in the US as American Depositary Receipts Track Higher in Friday Trading

MT Newswires Live

Analysts Have Conflicting Sentiments on These Healthcare Companies: TransMedics Group (TMDX), Regeneron (REGN) and Tarsus Pharmaceuticals (TARS)

Piper Sandler Remains a Buy on Regeneron (REGN)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/TBXU/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TBXU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","market":"US","secType":"STK","nameCN":"Direxion Daily Biotech Top 5 Bull 2X ETF","latestPrice":34.965,"timestamp":1791482450783,"preClose":37.9098,"halted":0,"volume":597,"delay":0,"changeRate":-0.0776791225487867,"floatShares":75001,"shares":75001,"eps":0,"marketStatus":"Trading","change":-2.9448,"latestTime":"10-08 14:04:25 EDT","open":34.965,"high":34.965,"low":34.965,"amount":20883.503570999997,"amplitude":0,"askPrice":35.89,"askSize":400,"bidPrice":35.78,"bidSize":400,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791489600000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":37.9098,"sharesOutstanding":100001,"nav":37.082,"aum":2781178.87,"dividendRate":0.021865,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":37.0661,"preClose":37.9098,"latestTime":"16:10 EDT","volume":6,"amount":227.4588,"timestamp":1791403804668,"change":-0.8437,"changeRate":-0.022255,"amplitude":0},"volumeRatio":0.895552},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","floatShares":75001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.895552,"shares":75001,"dividePrice":0.76452,"high":34.965,"amplitude":0,"preClose":37.9098,"low":34.965,"week52Low":25.71,"pbRate":"--","week52High":45.88,"institutionHeld":0,"latestPrice":34.965,"eps":0,"divideRate":0.021865,"volume":597,"delay":0,"ttmEps":0,"open":34.965,"prevYearClose":31.065,"prevWeekClose":36.95,"prevMonthClose":39.9,"prevQuarterClose":39.9,"fiveDayClose":37.9097,"twentyDayClose":38.8987,"sixtyDayClose":31.7049},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TBXU\",params:#limit:5,,,undefined,":[{"date":"2026-09-22","symbol":"TBXU","amount":0.14204,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-22","defaultRemindTime":1790083800000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-29","payableDate":"2026-09-22","currency":"USD","dateTimestamp":1790049600000,"payDate":"2026-09-29"},{"date":"2026-06-23","symbol":"TBXU","amount":0.11101,"announcedDate":"2026-06-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-23","defaultRemindTime":1782221400000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-23","currency":"USD","dateTimestamp":1782187200000,"payDate":"2026-06-30"},{"date":"2026-03-24","symbol":"TBXU","amount":0.09893,"announcedDate":"2026-03-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-24","defaultRemindTime":1774359000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-24","currency":"USD","dateTimestamp":1774324800000,"payDate":"2026-03-31"},{"date":"2025-12-23","symbol":"TBXU","amount":0.10111,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-31"},{"date":"2025-12-10","symbol":"TBXU","amount":0.31143,"announcedDate":"2025-12-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-10","defaultRemindTime":1765377000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-17","payableDate":"2025-12-10","currency":"USD","dateTimestamp":1765342800000,"payDate":"2025-12-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TBXU\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-10","recordDate":"2025-12-10","paymentDate":"2025-12-17","value":0.31143,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-31","value":0.10111,"currency":"USD"},{"executeDate":"2026-03-24","recordDate":"2026-03-24","paymentDate":"2026-03-31","value":0.09893,"currency":"USD"},{"executeDate":"2026-06-23","recordDate":"2026-06-23","paymentDate":"2026-06-30","value":0.11101,"currency":"USD"},{"executeDate":"2026-09-22","recordDate":"2026-09-22","paymentDate":"2026-09-29","value":0.14204,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TBXU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TBXU\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673762055","title":"Regeneron Pharmaceuticals - Sanofi Enter Sixth Amendment to License and Collaboration Agreement - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2673762055","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673762055?lang=en_us&edition=fundamental","pubTime":"2026-10-06 19:52","pubTimestamp":1791287557,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nFWN45S133:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0823434740.USD","TBXU","LU2468319806.SGD","LU2023250504.SGD","LU2362541513.USD","LU2106854487.HKD","LU2089984988.USD","BK4585","LU0114720955.EUR","BK4139","LU0882574055.USD","IBBQ","LU0823434583.USD","LU0823416689.USD","LU0289739699.SGD","LU0889565916.HKD","LU0053666078.USD","LU1917777945.USD","IBB","LU0058720904.USD","LU2362541273.HKD","BK4588","LU2324357040.USD","BBH","LU1974910355.USD","LU2237438978.USD","REGN","LU2362540622.SGD","LU0320765992.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673055796","title":"Regeneron Pharmaceuticals - Ipr&D Charge Expected to Reduce Q3 2026 Gaap and Non-Gaap EPS by $0.18 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2673055796","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673055796?lang=en_us&edition=fundamental","pubTime":"2026-10-06 19:52","pubTimestamp":1791287557,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nFWN45S133:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","LU1917777945.USD","LU1974910355.USD","LU2468319806.SGD","IBB","LU0109394709.USD","LU0882574055.USD","LU2106854487.HKD","LU0889565916.HKD","LU0320765992.SGD","LU2089984988.USD","TBXU","BK4585","IBBQ","LU0114720955.EUR","REGN","LU0823434740.USD","LU2324357040.USD","LU2362540622.SGD","LU0053666078.USD","LU0823416689.USD","LU2023250504.SGD","LU0289739699.SGD","BBH","LU2362541513.USD","LU0823434583.USD","BK4139","LU0058720904.USD","LU2237438978.USD","LU2362541273.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673053292","title":"Regeneron to Present Phase 3 C-POST Overall Survival Update for Adjuvant Libtayo in High-Risk CSCC at ESMO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2673053292","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673053292?lang=en_us&edition=fundamental","pubTime":"2026-10-06 19:02","pubTimestamp":1791284559,"startTime":"0","endTime":"0","summary":"Regeneron to present Phase 3 C-POST overall survival update for adjuvant Libtayo in high-risk CSCC at ESMO 2026Regeneron outlined 10 oncology and thrombosis abstracts scheduled for ESMO 2026 in Madrid","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nNDL47xpD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","BBH","IBBQ","BK4585","LU2362541513.USD","LU0058720904.USD","LU0823434740.USD","LU2468319806.SGD","LU0109394709.USD","IE00BQXX3F31.USD","SG9999014039.USD","LU2324357040.USD","LU2089984988.USD","BK4112","IE00BN0W2T93.GBP","BK4139","REGN","BK4588","IE00B3QW5Z07.USD","LU2106854487.HKD","LU0889565916.HKD","LU2362541273.HKD","NDAQ","LU2362540622.SGD","IE00BQXX3D17.EUR","LU2237438978.USD","IE00BN0W2W23.USD","LU2210150020.SGD","IE00BQXX3C00.GBP","LU0823416689.USD","LU0289739699.SGD","IBB","LU1917777945.USD","SG9999014005.SGD","IE00BGHQF748.EUR","LU0114720955.EUR","BCDF","LU0882574055.USD","IE00B64PRP62.GBP","LU1974910355.USD","LU0823434583.USD","LU0320765992.SGD","LU0314104364.USD","LU0053666078.USD","SG9999014021.USD","LU2095319765.USD","IE00BN0W2V16.EUR","LU2023250504.SGD","LU2210149790.SGD","IE00BKPKM429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673343210","title":"Sanofi Can Move Forward to Pursue Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2673343210","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673343210?lang=en_us&edition=fundamental","pubTime":"2026-10-06 15:10","pubTimestamp":1791270600,"startTime":"0","endTime":"0","summary":"0710 GMT - Sanofi needs mergers and acquisitions to refill its late-stage drug pipeline, and its recently expanded collaboration with Regeneron Pharmaceuticals means it can shift its focus to dealmaking, Berenberg analysts say in a research note. \"Sanofi can now move forward to deploy its [30 billion to 40 billion euros] of balance sheet capacity on business development,\" the analysts say. Since the drug candidates Sanofi and Regeneron will jointly develop are at an early stage, the French drugmaker has limited pivotal study results on the horizon, Berenberg says. Data on a late-stage trial for frexalimab in multiple sclerosis and a midstage for brivekimig in skin condition hidradenitis suppurativa due in the second half of 2027 are the next updates Berenberg will be watching, the analysts say. Sanofi shares rise 1%.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU2468319806.SGD","LU2023250504.SGD","IBBQ","LU0053666078.USD","LU2089984988.USD","LU2237438978.USD","LU2324357040.USD","SNY","BK4585","BK4007","SNYNF","REGN","LU0289739699.SGD","BBH","LU0114720955.EUR","TBXU","IBB","LU0109394709.USD","LU0889565916.HKD","LU0823416689.USD","BK4139","IE00BFXG1179.USD","LU0882574055.USD","BK4588","LU2362541513.USD","LU0823434583.USD","LU1917777945.USD","LU0823434740.USD","LU1974910355.USD","LU2362540622.SGD","LU2106854487.HKD","LU0320765992.SGD","LU2362541273.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673084939","title":"Moderna Inc. Stock Rises 6.9%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2673084939","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673084939?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:33","pubTimestamp":1791232380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. advanced 6.9% to $203.21 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.1% to 27,477.31 and the Dow Jones Industrial Average rising 0.2% to 51,267.90.This was the stock's second consecutive day of gains.Moderna Inc. closed 2.7% below its 52-week high of $208.90, which the company reached on September 29th.The stock outperformed some of its peers, as Johnson & Johnson fell 1.2% to $252.93, Pfizer Inc. fell 1.4% to $27.41, and Gilead Sciences Inc. fell 0.08% to $144.63.Trading volume totaled 18.8 million, compared to the 50-day average of 20.1 million.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","MRNX","BMED","GILD","GNOM","BK4568","LU1066051498.USD","BBH","BIB","LU1037948897.HKD","LU2357627491.SGD","LU0823416689.USD","SG9999015952.SGD","WDNA","BK4578","IE00BZ1G4Q59.USD","LU1674673691.USD","MRNA","TMED","LU0965509010.AUD","MEDI","MRNY","BK4588","IE00B7SZLL34.SGD","LU0861579265.USD","LU1674673428.USD","BK4585","SG9999015945.SGD","BK4583","IDNA","LU0109394709.USD","BK4551","LU1839511570.USD","LU1057294990.SGD","BK4532","LU1061106388.HKD","LU2087621335.USD","LU0965509101.SGD","BK4533","IBBQ","LU0234570918.USD","IE00B19Z3B42.SGD","BK4139","BK4566","LGHT","LU2112291526.USD","LU1934455277.USD","TBXU","LU1778281490.HKD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673086684","title":"Vortex Energy Launches Study on Natural Hydrogen and Helium at Robinsons River Salt Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2673086684","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673086684?lang=en_us&edition=fundamental","pubTime":"2026-10-06 00:38","pubTimestamp":1791218328,"startTime":"0","endTime":"0","summary":"Vortex Energy Corp. ( ($TSE:VRTX) ) has issued an update. Vortex Energy Corp. has commissioned Lonquist Field Service (Canada), ULC to conduct a de...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vortex-energy-launches-study-on-natural-hydrogen-and-helium-at-robinsons-river-salt-project?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vortex-energy-launches-study-on-natural-hydrogen-and-helium-at-robinsons-river-salt-project?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","SG9999013999.USD","VRTX","LU2237438978.USD","TBXU","LU0079474960.USD","IE00B4R5TH58.HKD","LU2324357040.USD","LU2362541273.HKD","IE00B894F039.SGD","GNMX","LU0320765992.SGD","SGXZ57979304.SGD","IE0002141913.USD","IE00BFTCPJ56.SGD","IBBQ","LU2456880835.USD","LU2362540622.SGD","HYDR","PBE","BK4533","LU1035775433.USD","BK4567","LU2468319806.SGD","LU1585245621.USD","BIB","SG9999001176.SGD","BBH","IDNA","IE0009355771.USD","BK4585","LU0417517546.SGD","IE00BJT1NW94.SGD","BK4588","LU0058720904.USD","LU1778281490.HKD","BK4532","BK4139","LU2362541513.USD","LU0109394709.USD","LU1093756168.USD","LU2089984988.USD","IBB","IE0002270589.USD","IE00BZ9MQY76.HKD","IE00B19Z9Z06.USD","IE00B19Z3581.USD","IE00B19Z9P08.USD","LU0234570918.USD","LU2236285917.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673704303","title":"Nurix, Gilead Extend Research Term for Oncology Program by Two Years for $10 Million Fee","url":"https://stock-news.laohu8.com/highlight/detail?id=2673704303","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673704303?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:03","pubTimestamp":1791198202,"startTime":"0","endTime":"0","summary":"Nurix, Gilead extend research term for oncology program by two years for $10 million feeNurix Therapeutics extended the research term for an undisclosed oncology program under its strategic collaborat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDL7nTmpm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1037948541.HKD","LU0965509101.SGD","SG9999015945.SGD","LU2087621335.USD","TBXU","LU2468319806.SGD","GILD","LU0965509010.AUD","NRIX","SG9999015986.USD","BK4583","LU1057294990.SGD","LU1430594728.SGD","IE00BQXX3D17.EUR","LU1934455277.USD","TMED","SG9999014021.USD","BMED","IE0002270589.USD","IE00BQXX3F31.USD","BK4568","BK4585","LU0859254822.USD","LU2210150020.SGD","BK4112","LU0882574055.USD","IBBQ","LU1934455194.USD","BIB","IE00BN0W2W23.USD","BK4578","LU0289739699.SGD","SG9999015978.USD","LU0861579265.USD","IE00B3T34201.USD","NDAQ","IBB","LU0058720904.USD","LU0314104364.USD","BCDF","IE00BZ1G4Q59.USD","LU1066051498.USD","LU1037948897.HKD","MEDI","BBH","BK4566","LU0965509283.SGD","LU0320765992.SGD","LU1839511570.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673704306","title":"Nurix Extends Gilead Collaboration for Oncology Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2673704306","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673704306?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:03","pubTimestamp":1791198199,"startTime":"0","endTime":"0","summary":"BRIEF-Nurix Extends Gilead Collaboration For Oncology ProgramOct 5 (Reuters)-Nurix Therapeutics, Inc.NRIX.O:NURIX THERAPEUTICS ANNOUNCES SECOND RESEARCH TERM EXTENSION FOR ONCOLOGY PROGRAM UNDER COLLA","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA7MVP3J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0965509101.SGD","LU1839511570.USD","TBXU","LU2468319806.SGD","IE00B7SZLL34.SGD","NRIX","IE00B19Z3B42.SGD","IBB","IE00BSNM7G36.USD","LU0058720904.USD","LU2324357040.USD","LU0320765992.SGD","LU1934455194.USD","BK4566","BBH","LU0882574055.USD","SG9999015952.SGD","LU0965508806.USD","LU0965509010.AUD","IE00B3T34201.USD","BK4550","IE00BKVL7J92.USD","LU1037948897.HKD","SG9999015978.USD","LU1585245621.USD","LU0109394709.USD","BK4139","BK4568","BMED","LU1023059063.AUD","LU2089984988.USD","LU1934455277.USD","LU2087621335.USD","IE0002270589.USD","LU0122379950.USD","LU1571399168.USD","IBBQ","LU0861579265.USD","LU0965509283.SGD","LU1066053197.SGD","LU1057294990.SGD","LU2357627491.SGD","LU1934455863.HKD","MEDI","LU0859254822.USD","TMED","SG9999015945.SGD","BIB","LU1674673691.USD","GILD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673704828","title":"Nurix - Eligible for up to $1.30 Bln in Total Payments as of May 31, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2673704828","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673704828?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:00","pubTimestamp":1791198000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA7MVP3J:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0114720955.EUR","LU0058720904.USD","LU1037948897.HKD","BBH","LU0234570918.USD","IE00BKVL7J92.USD","TMED","LU0965509283.SGD","NRIX","BK4566","BK4550","LU1934455277.USD","LU1839511570.USD","LU0122379950.USD","LU0823416689.USD","SG9999015978.USD","LU1934455194.USD","LU2324357040.USD","LU2112291526.USD","IE00BSNM7G36.USD","LU1066053197.SGD","BK4588","IE00B3T34201.USD","IBB","IE00B7SZLL34.SGD","BK4585","IE00B19Z3B42.SGD","BK4139","TBXU","IBBQ","IE00BZ1G4Q59.USD","LU0289739699.SGD","BK4532","LU0859254822.USD","MEDI","LU1585245621.USD","BK4568","BMED","LU1571399168.USD","BK4583","LU1778281490.HKD","LU0861579265.USD","LU0882574055.USD","LU0320765992.SGD","BK4578","LU1023059063.AUD","BIB","LU2089984988.USD","GILD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673048487","title":"Nurix - Eligible for Mid-Single-Digit to Low-Teens Percentage Tiered Royalties","url":"https://stock-news.laohu8.com/highlight/detail?id=2673048487","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673048487?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:00","pubTimestamp":1791198000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA7MVP3J:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999015986.USD","BIB","IE00B3T34201.USD","LU0889565916.HKD","LU1066053197.SGD","LU1934455863.HKD","BMED","LU1023059063.AUD","LU0122379950.USD","LU0823416689.USD","MEDI","LU0859254822.USD","LU0965509010.AUD","LU2468319806.SGD","LU0289739699.SGD","IE00BSNM7G36.USD","SG9999015952.SGD","LU2087621335.USD","LU1839511570.USD","NRIX","LU1037948541.HKD","IE00B19Z3B42.SGD","LU1430594728.SGD","IE00BZ1G4Q59.USD","IE0002270589.USD","TMED","BK4568","LU1057294990.SGD","LU1571399168.USD","BK4550","GILD","LU1778281490.HKD","LU1066051498.USD","LU0861579265.USD","LU0320765992.SGD","LU0234570918.USD","SG9999015945.SGD","LU1934455194.USD","IE00B19Z3581.USD","LU2089984988.USD","BBH","IBBQ","LU1674673428.USD","IE00BKVL7J92.USD","LU1037948897.HKD","LU0965509283.SGD","BK4566","IBB","TBXU","LU0965509101.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673048127","title":"Nurix - to Receive $10 Mln Research Term Extension Fee","url":"https://stock-news.laohu8.com/highlight/detail?id=2673048127","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673048127?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:00","pubTimestamp":1791198000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA7MVP3J:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0889565916.HKD","TMED","LU1037948897.HKD","SG9999015945.SGD","BK4566","IE0002270589.USD","LU1430594728.SGD","LU1934455194.USD","LU2087621335.USD","SG9999015952.SGD","LU0320765992.SGD","IBB","LU0965509101.SGD","LU1037948541.HKD","LU0861579265.USD","LU0965509283.SGD","MEDI","IE00BKVL7J92.USD","SG9999015986.USD","LU1023059063.AUD","LU2468319806.SGD","TBXU","LU2089984988.USD","BMED","LU1571399168.USD","IBBQ","BK4550","LU1934455863.HKD","LU0122379950.USD","LU1066051498.USD","BIB","IE00BSNM7G36.USD","LU1674673428.USD","LU0289739699.SGD","BK4568","IE00B19Z3581.USD","LU0234570918.USD","LU0965509010.AUD","LU1066053197.SGD","LU0823416689.USD","LU1839511570.USD","LU1778281490.HKD","LU0859254822.USD","BBH","IE00B3T34201.USD","LU1057294990.SGD","IE00BZ1G4Q59.USD","IE00B19Z3B42.SGD","GILD","NRIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673021701","title":"Nurix - Retains Co-Development and 50/50 Profit Sharing Options on Two U.S. Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2673021701","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673021701?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:00","pubTimestamp":1791198000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA7MVP3J:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0320765992.SGD","LU1778281490.HKD","LU1839511570.USD","BK4532","BK4568","LU0109394709.USD","LU1057294990.SGD","LU1934455277.USD","LU2087621335.USD","LU0889565916.HKD","BMED","LU0965509010.AUD","LU1571399168.USD","LU0965509283.SGD","BK4583","LU2468319806.SGD","LU0058720904.USD","SG9999015945.SGD","LU0861579265.USD","TMED","LU1066053197.SGD","LU1066051498.USD","IE00BSNM7G36.USD","BBH","SG9999015986.USD","IBB","BIB","IE0002270589.USD","IBBQ","LU1037948541.HKD","LU0289739699.SGD","IE00BZ1G4Q59.USD","LU1037948897.HKD","TBXU","LU0882574055.USD","LU1934455194.USD","MEDI","BK4585","LU1430594728.SGD","LU0859254822.USD","LU0965509101.SGD","BK4578","SG9999015978.USD","NRIX","IE00B3T34201.USD","GILD","LU1061106388.HKD","BK4566","IE00B19Z3B42.SGD","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672749473","title":"Gilead CEO Daniel O’Day Disposes of USD 2,216,507.50 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2672749473","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672749473?lang=en_us&edition=fundamental","pubTime":"2026-10-03 04:42","pubTimestamp":1790973757,"startTime":"0","endTime":"0","summary":"Gilead CEO Daniel O’Day disposes of USD 2,216,507.50 in common sharesGilead Sciences Chairman and CEO Daniel Patrick O’Day sold 15,000 common shares on Oct. 1, 2026.Sales were priced at USD 147.719 an","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL7B1xgm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gilead CEO Daniel O’Day Disposes of USD 2,216,507.50 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","TBXU","LU2324357040.USD","LU1037948897.HKD","LU0114720955.EUR","LU0823416689.USD","IE00B19Z3B42.SGD","LU0320765992.SGD","LU1674673428.USD","BK4578","IBBQ","LU0859254822.USD","LU2357627491.SGD","IE00BSNM7G36.USD","MEDI","BK4550","LU0965509101.SGD","LU2468319806.SGD","TMED","LU1571399168.USD","LU1585245621.USD","BIB","LU0289739699.SGD","BBH","LU0965508806.USD","BK4585","BMED","LU0058720904.USD","BK4588","SG9999015986.USD","LU1778281490.HKD","BK4532","LU1023059063.AUD","LU1066051498.USD","SG9999015978.USD","LU0109394709.USD","IE00BKVL7J92.USD","LU2087621335.USD","LU1430594728.SGD","LU1934455194.USD","GILD","LU2089984988.USD","IBB","IE0002270589.USD","LU0861579265.USD","LU1934455863.HKD","LU1934455277.USD","IE00B19Z3581.USD","LU0882574055.USD","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672749136","title":"Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672749136","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672749136?lang=en_us&edition=fundamental","pubTime":"2026-10-03 04:35","pubTimestamp":1790973300,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  slid 1.87% to $144.74 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.73% to 7,722.72 and the Dow Jones Industrial Average  rising 0.49% to 51,176.96.This was the stock's fourth consecutive day of losses.Gilead Sciences Inc. closed 7.98% below its 52-week high of $157.29, which the company achieved on February 11th.The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson  fell 1.02% to $256.03, Pfizer Inc.  fell 1.14% to $27.80, and Abbott Laboratories  rose 0.84% to $97.50.Trading volume  remained 1.3 million below its 50-day average volume of 6.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 2, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKVL7J92.USD","BK4139","LU0114720955.EUR","LU1571399168.USD","LU1934455277.USD","TMED","LU2468319806.SGD","IE00BZ1G4Q59.USD","IE00BSNM7G36.USD","LU0234570918.USD","LU2087621335.USD","LU2089984988.USD","BK4585","SG9999015978.USD","LU0882574055.USD","LU1934455863.HKD","IBBQ","BK4532","LU0965508806.USD","IE00B3T34201.USD","LU1839511570.USD","BK4568","LU0289739699.SGD","MEDI","LU0058720904.USD","LU0965509010.AUD","IE00B7SZLL34.SGD","LU0122379950.USD","BK4566","LU0889565916.HKD","LU2112291526.USD","LU1037948541.HKD","BK4588","LU1037948897.HKD","BMED","IE00B19Z3B42.SGD","LU0965509101.SGD","LU1057294990.SGD","LU0320765992.SGD","LU1430594728.SGD","LU0859254822.USD","IBB","LU0823416689.USD","LU0965509283.SGD","LU1066051498.USD","LU1674673428.USD","LU2324357040.USD","SG9999015945.SGD","BK4583","LU2357627491.SGD","LU0109394709.USD","SG9999015986.USD","BK4578","BK4550","LU1585245621.USD","LU1061106388.HKD","LU1778281490.HKD","LU0861579265.USD","LU1066053197.SGD","LU1934455194.USD","IE0002270589.USD","SG9999015952.SGD","LU1023059063.AUD","GILD","IE00B19Z3581.USD","TBXU","BBH","BIB","LU1674673691.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672749900","title":"Amgen Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672749900","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672749900?lang=en_us&edition=fundamental","pubTime":"2026-10-03 04:34","pubTimestamp":1790973240,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  slipped 1.04% to $403.04 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.73% to 7,722.72 and the Dow Jones Industrial Average  rising 0.49% to 51,176.96.This was the stock's third consecutive day of losses.Amgen Inc. closed 9.84% short of its 52-week high of $447.03, which the company achieved on August 25th.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson  fell 1.02% to $256.03, Pfizer Inc.  fell 1.14% to $27.80, and AbbVie Inc.  rose 1.11% to $262.82.Trading volume  eclipsed its 50-day average volume of 2.9 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 2, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU0058720904.USD","BK4566","LU2242646821.SGD","IE00B4R5TH58.HKD","LU0320765992.SGD","LU0109394709.USD","IBB","SG9999001440.SGD","BK4139","AMGN","BK4581","LU1023059063.AUD","IE0002141913.USD","04332","IE00BJT1NW94.SGD","LU2468319806.SGD","LU2112291526.USD","TBXU","BK4533","LU0868494617.USD","LU2089984988.USD","LU1571399168.USD","IBBQ","LU0122379950.USD","BIB","IE00BFTCPJ56.SGD","BK4534","BK4599","LU0289739699.SGD","IE0009355771.USD","PJP","BK4588","IE00B2B36J28.USD","LU1061106388.HKD","PBE","BBH","BK4585","LU1057294990.SGD","LU2242652126.USD","LU1983299246.USD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672034743","title":"Legend Biotech Faces Pressure From Rivals Ahead of Key FDA Decision, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2672034743","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672034743?lang=en_us&edition=fundamental","pubTime":"2026-10-03 01:05","pubTimestamp":1790960723,"startTime":"0","endTime":"0","summary":"Legend Biotech's (LEGN) multiple myeloma therapy Carvykti is facing growing competitive pressure as Gilead Sciences' (GILD) anito-cel approaches a potential approval and Johnson & Johnson's (JNJ) Tec-","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TBXU","VHT","TMED","LU0545562505.USD","IE0034235303.USD","IE00BKVL7J92.USD","LU1057294990.SGD","GDOC","FTXH","MEDX","JNJ","LU0426417589.USD","IE00BLSP4239.USD","BK4550","CANC","GILD","LEGN","LU0345769631.USD","LU0545039389.USD","IBBQ","LU0345770308.USD","LU0889566641.SGD","FHLC","IE00BLSP4452.SGD","SG9999001440.SGD","LU2129689605.HKD","LU0320765992.SGD","BMED","BIB","IHE","IXJ","PJP","MEMS","XLV","XBI","LU1261432733.SGD","IE00B42XCP33.USD","LU1162221912.USD","TRUH","JDOC","IYH","LABU","LU1585245621.USD","MEDI","BBH","LU1221951046.USD","RXL","IBB","BK4504","LU0859254822.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672174313","title":"Amgen’s Evolocumab Study Signals Quiet Efficiency Gains for Cholesterol Franchise","url":"https://stock-news.laohu8.com/highlight/detail?id=2672174313","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672174313?lang=en_us&edition=fundamental","pubTime":"2026-10-03 00:30","pubTimestamp":1790958636,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen’s AMGN Evolocumab Study Highlights Subtle Edge in Cholesterol Drug Del...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgens-evolocumab-study-signals-quiet-efficiency-gains-for-cholesterol-franchise?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgens-evolocumab-study-signals-quiet-efficiency-gains-for-cholesterol-franchise?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2242646821.SGD","IE0009355771.USD","IE00B2B36J28.USD","LU0058720904.USD","IE00BFTCPJ56.SGD","BBH","LU0109394709.USD","LU0868494617.USD","BK4566","LU1057294990.SGD","LU0122379950.USD","LU0889565916.HKD","BK4599","BK4534","LU2112291526.USD","BK4588","IE0002141913.USD","IE00BJJMRZ35.SGD","PJP","PBE","IBB","SG9999001440.SGD","BK4585","LU1983299246.USD","BK4139","BK4533","TBXU","IBBQ","LU0289739699.SGD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","AMGN","LU1571399168.USD","BK4581","LU2468319806.SGD","LU0320765992.SGD","LU1023059063.AUD","BIB","LU2089984988.USD","LU2242652126.USD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672748843","title":"European Equities Traded in the US as American Depositary Receipts Track Higher in Friday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2672748843","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672748843?lang=en_us&edition=fundamental","pubTime":"2026-10-02 23:05","pubTimestamp":1790953529,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were trending higher late Friday morning, rising 0.59% to 1,883.71 on the S&P Europe Select ADR Index, which has shed close to 2% for","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DAVA","LU0300736492.USD","COAL","LU0084288595.USD","SLN","CLLS","AUTL","BK4141","DAVA.AU","LU0300736062.USD","ARGX","BDRX","LNOK","LU2324357040.USD","BK7507","NGG","SNY","LU0648005311.SGD","BK4134","BK4007","BK4077","BK4132","BK4020","LU1983260115.SGD","SLX","SQNS","IE00BMPRXR70.SGD","BHP.AU","EPV","IE00B2B36J28.USD","TBXU","ERIC","BK7511","IBB","LU0889565916.HKD","BK4082","TRVG","BK4139","LU0823416689.USD","BHP","VOD","BK4588","IEUR","TRIB","DBVT","IE0034235188.USD","NOK","AFG","IE00BJJMRZ35.SGD","FMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672714416","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: TransMedics Group (TMDX), Regeneron (REGN) and Tarsus Pharmaceuticals (TARS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672714416","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672714416?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:30","pubTimestamp":1790944215,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on TransMedics Group (TMDX), Regeneron (REGN) and Tar...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-transmedics-group-tmdx-regeneron-regn-and-tarsus-pharmaceuticals-tars-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-transmedics-group-tmdx-regeneron-regn-and-tarsus-pharmaceuticals-tars-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TMDX","LU0128526141.USD","LU1917777945.USD","LU2468319806.SGD","LABU","BBH","HCSG","BK4585","LU2362541273.HKD","LU0882574055.USD","LU0823434740.USD","BK4139","LU0889565916.HKD","LU2362541513.USD","REGN","BK4007","LU2237438978.USD","LU0823416689.USD","TBXU","LU2065731478.USD","IBB","BK4137","LU2106854487.HKD","LU0114720955.EUR","IBBQ","BK4581","LU2023250504.SGD","XBI","LU0320765992.SGD","BK4588","LU0053666078.USD","LU2362540622.SGD","BK4082","LU0289739699.SGD","LU2089984988.USD","LU2324357040.USD","TARS","LU0823434583.USD","XLV","LU0029874061.USD","LU0058720904.USD","LU1974910355.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672071900","title":"Piper Sandler Remains a Buy on Regeneron (REGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672071900","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672071900?lang=en_us&edition=fundamental","pubTime":"2026-10-02 19:35","pubTimestamp":1790940929,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Biren Amin maintained a Buy rating on Regeneron today and set a price target of $854.00. Amin covers the Healthcare sector, f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-remains-a-buy-on-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-remains-a-buy-on-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1917777945.USD","LU2468319806.SGD","LABU","BBH","BK4585","LU2362541273.HKD","LU0882574055.USD","LU0823434740.USD","BK4139","LU0889565916.HKD","LU2362541513.USD","REGN","LU2237438978.USD","LU0823416689.USD","TBXU","IBB","LU2106854487.HKD","LU0114720955.EUR","IBBQ","BK4581","LU2023250504.SGD","XBI","LU0320765992.SGD","BK4588","LU0053666078.USD","LU2362540622.SGD","LU0289739699.SGD","LU2089984988.USD","LU2324357040.USD","LU0823434583.USD","XLV","LU0058720904.USD","LU1974910355.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}